119-sres422

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 422 Agreed to Senate

    (ATS) ]

<DOC>

119th CONGRESS
 1st Session
S. RES. 422

 Recognizing the seriousness of polycystic ovary syndrome

    (PCOS) and 
 expressing support for the designation of September 2025 as ``PCOS 
 Awareness Month''.

_______________________________________________________________________

 IN THE SENATE OF THE UNITED STATES

 September 30, 2025

Ms. Warren (for herself, Mrs. Fischer, Mr. Blumenthal, Mr. Padilla, Mr. 
Van Hollen, Mr. Marshall, Mr. Lankford, and Mr. Warnock) submitted the 
 following resolution; which was referred to the Committee on Health, 
 Education, Labor, and Pensions

 October 6, 2025

 Committee discharged; considered and agreed to

_______________________________________________________________________

 RESOLUTION

 Recognizing the seriousness of polycystic ovary syndrome

    (PCOS) and 
 expressing support for the designation of September 2025 as ``PCOS 
 Awareness Month''.

Whereas polycystic ovary syndrome (referred to in this preamble as ``PCOS'') is 
 a common health problem among women and girls involving a hormonal 
 imbalance;
Whereas there is no universal definition of PCOS, but researchers estimate that 
 10 percent of women in the United States are affected by the condition;
Whereas, according to a 2023 study, the annual burden of PCOS in the United 
 States is estimated to be in excess of $15,000,000,000, and this 
 estimate does not include--

    (1) the cost of all comorbidities in post-menopause or adolescence; or

    (2) indirect and intangible costs related to the disorder;

Whereas PCOS can affect girls at the onset of puberty and throughout the 
 remainder of their lives;
Whereas the symptoms of PCOS include infertility, irregular or absent menstrual 
 periods, acne, weight gain, thinning of scalp hair, excessive facial and 
 body hair growth, numerous small ovarian cysts, pelvic pain, and mental 
 health problems;
Whereas women with PCOS have higher rates of mental health disorders, including 
 depression, anxiety, bipolar disorder, and eating disorders, and are at 
 greater risk for suicide;
Whereas adolescents with PCOS often are not diagnosed, and many have metabolic 
 dysfunction and insulin resistance, which can lead to type 2 diabetes, 
 cardiovascular disease, obstructive sleep apnea, nonalcoholic fatty 
 liver disease, heart disease, and endometrial cancer at a young adult 
 age;
Whereas an estimated 70 percent of women with PCOS are undiagnosed and many 
 remain undiagnosed until they experience fertility difficulties or 
 develop type 2 diabetes or other cardiometabolic disorders;
Whereas PCOS is one of the most common causes of female infertility;
Whereas PCOS in pregnancy is associated with increased risk of gestational 
 diabetes, preeclampsia, pregnancy-induced hypertension, preterm 
 delivery, cesarean delivery, miscarriage, and fetal and infant death;
Whereas women with PCOS are at increased risk of developing high blood pressure, 
 high cholesterol, stroke, and heart disease (the leading cause of death 
 among women);
Whereas women with PCOS have a more than 50 percent chance of developing type 2 
 diabetes or prediabetes before the age of 40;
Whereas PCOS may be associated with increased risk for breast cancer and ovarian 
 cancer, and the risk of developing endometrial cancer is 4 times higher 
 than for women who do not have PCOS;
Whereas research has found an association between depression and PCOS;
Whereas research has indicated PCOS shares a genetic architecture with metabolic 
 traits, as evidenced by genetic correlations between PCOS and obesity, 
 fasting insulin, type 2 diabetes, lipid levels, and coronary artery 
 disease;
Whereas PCOS negatively alters metabolic function independent of, but 
 exacerbated by, an increased body mass index (commonly referred to as 
 ``BMI'');
Whereas the cause of PCOS is unknown, but researchers have found strong links to 
 a genetic predisposition and significant insulin resistance, which 
 affects up to 70 percent of women with PCOS; and
Whereas there is no known cure for PCOS: Now, therefore, be it
 Resolved, That the Senate--

    (1) recognizes polycystic ovary syndrome (referred to in 
 this resolution as ``PCOS'') as a serious disorder that impacts 
 many aspects of health, including cardiometabolic, 
 reproductive, and mental health, and quality of life;

    (2) expresses support for the designation of September 2025 
 as ``PCOS Awareness Month'';

    (3) supports the goals and ideals of PCOS Awareness Month, 
 which are--
        (A) to increase awareness of, and education about, 
 PCOS and its connection to comorbidities, such as type 
 2 diabetes, endometrial cancer, cardiovascular disease, 
 nonalcoholic fatty liver disease, and mental health 
 disorders, among the general public, women, girls, and 
 health care professionals;
        (B) to improve diagnosis and treatment of PCOS;
            (C) to disseminate information on diagnosis, 
 treatment, and management of PCOS, including prevention 
 of comorbidities such as type 2 diabetes, endometrial 
 cancer, cardiovascular disease, nonalcoholic fatty 
 liver disease, and eating disorders; and
            (D) to improve quality of life and outcomes for 
 women and girls with PCOS;

    (4) recognizes the need for further research, improved 
 treatment and care options, and a cure for PCOS;

    (5) acknowledges the struggles affecting all women and 
 girls who have PCOS in the United States;

    (6) urges medical researchers and health care professionals 
 to advance their understanding of PCOS to improve research, 
 diagnosis, and treatment of PCOS for women and girls; and

    (7) encourages States, territories, and localities to 
 support the goals and ideals of PCOS Awareness Month.
 <all>